Worth Venture Partners, LLC Dia Medica Therapeutics Inc. Transaction History

Worth Venture Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 17, 2021	SELL	$4.13 - $10.14 $177,123 - $434,874	-42,887 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$3.91 - $7.15 $167,688 - $306,642	42,887 New	42,887 $182,000
Q2 2020 Aug 14, 2020	SELL	$2.6 - $7.32 $275,189 - $774,763	-105,842 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.25 - $5.64 $36,706 - $92,010	-16,314 Reduced 13.36%	105,842 $296,000
Q4 2019 Feb 14, 2020	SELL	$1.8 - $5.04 $35,361 - $99,010	-19,645 Reduced 13.85%	122,156 $593,000
Q3 2019 Nov 12, 2019	BUY	$2.07 - $4.88 $19,224 - $45,320	9,287 Added 7.01%	141,801 $294,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $4.96 $34,157 - $62,748	12,651 Added 10.55%	132,514 $657,000
Q1 2019 May 15, 2019	SELL	$3.1 - $4.54 $31,000 - $45,400	-10,000 Reduced 7.7%	119,863 $544,000
Q4 2018 Feb 15, 2019	BUY	$2.65 - $9.2 $344,136 - $1.19 Million	129,863 New	129,863 $377,000

3.87M

1.3K

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $116M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Worth Venture Partners, LLC with notifications on news.